<Anchor> The
European Medicines Agency has concluded that the AstraZeneca vaccine and the phenomenon of blood clots are not related.
Some of the European countries that temporarily suspended vaccinations have said they would start vaccinating again immediately.
Reporter Kang Cheong-wan reports.
<Reporter> The
European Medicines Agency has announced that it has concluded that it has concluded a clear and scientific conclusion that the AstraZeneca vaccine is not related to blood clots.
The AstraZeneca vaccine is still safe and effective, he stressed that the benefits of the vaccination outweigh the risks.
[Emer Cook/European Medicines Commissioner: concluded that the AstraZeneca vaccine was not associated with an increased overall risk of developing embolism or blood clots.]
Europe The Drug Administration added that it was only very rare and could not completely rule out the association with the vaccine in certain cases of blood clots.
Of the 20 million people vaccinated, 25 rare cases of blood clots occurred, of which 9 died.
Even if it is extremely small, it has revealed that it will continue with further analysis and observation as the possibility remains.
[Sabine Strauss/Chairman of the European Medicines Agency Safety Committee: We will continue to collect more information and further research on vaccines and blood clots, as well as closely monitor cases of blood clots.]
Among the countries that stopped vaccination according to the European authorities' announcement, Germany has stopped vaccination. And Spain have announced policies to resume vaccinations.
Earlier, in Europe, as there were reports of blood clots after vaccination with AstraZeneca, countries such as Germany, France, and Italy temporarily suspended vaccination.